Skye Bioscience, Inc. (SKYE)
1.16
-0.05
(-4.13%)
USD |
NASDAQ |
Dec 10, 16:00
1.16
0.00 (0.00%)
After-Hours: 20:00
Skye Bioscience Total Assets (Quarterly): 41.32M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 294.82M |
| Theravance Biopharma, Inc. | 415.46M |
| Viking Therapeutics, Inc. | 739.42M |
| FibroGen, Inc. | 137.01M |
| Myomo, Inc. | 34.08M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.488M |
| Shareholders Equity (Quarterly) | 32.84M |
| Debt to Equity Ratio | 0.0098 |
| Current Ratio | 4.771 |
| Net Debt Paydown Yield | 0.78% |